Keywords: alnylam, wins, 6m, biodefense, contract, pharmaceuticals, rnai

Alnylam wins $38.6M US biodefense contract

Article | 20 August 2007

Alnylam Pharmaceuticals, a US RNAi therapeutics specialist, has been awarded a $38.6 million contract over 33 months from the US Defense Threat ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Alnylam Pharmaceuticals

Go to company listing